|
Volumn 38, Issue 10, 2006, Pages 3625-3628
|
A Cyclosporine-Based Immunosuppressive Regimen May Be Better Than Tacrolimus for Long-Term Liver Allograft Survival in Recipients Transplanted for Hepatitis C
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
INTERFERON;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
RIBAVIRIN;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
ARTICLE;
CHOLESTATIC HEPATITIS;
CONTROLLED STUDY;
DATA BASE;
DISEASE SEVERITY;
DRUG EFFICACY;
FEMALE;
GRAFT SURVIVAL;
HEPATITIS C;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER FIBROSIS;
LIVER GRAFT REJECTION;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RECURRENT DISEASE;
TREATMENT OUTCOME;
BIOPSY;
CYCLOSPORINE;
DATABASES, FACTUAL;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATITIS C;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
LONGITUDINAL STUDIES;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
RETROSPECTIVE STUDIES;
TACROLIMUS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 33845382311
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2006.10.040 Document Type: Article |
Times cited : (22)
|
References (8)
|